erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Drug-Related Side Effects and Adverse Reactions D064420 3 associated lipids
Vagus Nerve Injuries D061223 1 associated lipids
Occupational Injuries D060051 1 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Acute Lung Injury D055371 33 associated lipids
Atrioventricular Block D054537 1 associated lipids
Pneumonia, Ventilator-Associated D053717 1 associated lipids
Kidney Diseases, Cystic D052177 3 associated lipids
Granulomatosis, Orofacial D051261 2 associated lipids
Seroma D049291 2 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Pyloric Stenosis, Hypertrophic D046248 2 associated lipids
Moraxellaceae Infections D045828 3 associated lipids
Desulfovibrionaceae Infections D045824 5 associated lipids
Ileus D045823 3 associated lipids
Acalculous Cholecystitis D042101 3 associated lipids
Pelvic Infection D034161 1 associated lipids
Communicable Diseases, Emerging D021821 3 associated lipids
Neuroaspergillosis D020953 2 associated lipids
Epidural Abscess D020802 1 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Postoperative Nausea and Vomiting D020250 1 associated lipids
Dermatitis, Perioral D019557 4 associated lipids
Postoperative Hemorrhage D019106 7 associated lipids
Sepsis D018805 11 associated lipids
Abdominal Abscess D018784 2 associated lipids
Arthralgia D018771 8 associated lipids
Gastroparesis D018589 2 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Lymphoma, B-Cell, Marginal Zone D018442 1 associated lipids
Pneumonia, Bacterial D018410 16 associated lipids
Adrenocortical Carcinoma D018268 4 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Limb Deformities, Congenital D017880 4 associated lipids
Granuloma, Pyogenic D017789 2 associated lipids
Community-Acquired Infections D017714 8 associated lipids
Retropharyngeal Abscess D017703 2 associated lipids
Lung Diseases, Interstitial D017563 5 associated lipids
Pityriasis Rosea D017515 3 associated lipids
Pityriasis Lichenoides D017514 2 associated lipids
Acneiform Eruptions D017486 3 associated lipids
Skin Diseases, Vascular D017445 1 associated lipids
Skin Diseases, Papulosquamous D017444 2 associated lipids
Gastric Outlet Obstruction D017219 1 associated lipids
Skin Diseases, Viral D017193 2 associated lipids
Skin Diseases, Bacterial D017192 8 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Chalazion D017043 1 associated lipids
Angiomatosis, Bacillary D016917 2 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Ehrlichiosis D016873 2 associated lipids
Neisseriaceae Infections D016870 3 associated lipids
Ureaplasma Infections D016869 5 associated lipids
Death, Sudden, Cardiac D016757 12 associated lipids
Empyema, Pleural D016724 2 associated lipids
Critical Illness D016638 13 associated lipids
Vaginosis, Bacterial D016585 10 associated lipids
Purpura, Thrombocytopenic, Idiopathic D016553 4 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Foot Ulcer D016523 4 associated lipids
Bacteremia D016470 9 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Torsades de Pointes D016171 2 associated lipids
Pleural Effusion, Malignant D016066 6 associated lipids
Eye Infections, Parasitic D015822 2 associated lipids
Erythema Chronicum Migrans D015787 3 associated lipids
Granuloma, Respiratory Tract D015769 1 associated lipids
Ethmoid Sinusitis D015521 2 associated lipids
Weight Gain D015430 101 associated lipids
Scleritis D015423 3 associated lipids
Mycobacterium avium-intracellulare Infection D015270 4 associated lipids
Sexually Transmitted Diseases, Bacterial D015231 5 associated lipids
Superinfection D015163 3 associated lipids
Yaws D015001 4 associated lipids
Xerostomia D014987 6 associated lipids
Wounds, Gunshot D014948 2 associated lipids
Wound Infection D014946 12 associated lipids
Whooping Cough D014917 6 associated lipids
Vulvovaginitis D014848 2 associated lipids
Vomiting D014839 21 associated lipids
Vibrio Infections D014735 5 associated lipids
Varicose Ulcer D014647 4 associated lipids
Uveitis D014605 14 associated lipids
Urticaria D014581 13 associated lipids
Urinary Tract Infections D014552 11 associated lipids
Urethritis D014526 9 associated lipids
Urethral Diseases D014522 4 associated lipids
Uremia D014511 33 associated lipids
Typhus, Epidemic Louse-Borne D014438 1 associated lipids
Typhus, Endemic Flea-Borne D014437 3 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Tuberculosis D014376 20 associated lipids
Trisomy D014314 6 associated lipids
Trench Fever D014205 1 associated lipids
Tremor D014202 15 associated lipids
Toxoplasmosis, Animal D014124 5 associated lipids
Toothache D014098 3 associated lipids
Tooth, Impacted D014095 9 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Horn S et al. Cholestasis and liver cell damage due to hypersensitivity to erythromycin stearate--recurrence following therapy with erythromycin succinate. 1999 Wien. Klin. Wochenschr. pmid:10081126
PROTIVINSKY R and ZELLINGER O [Therapy of mixed infection tuberculous empyema; preliminary report]. 1958 Wien. Klin. Wochenschr. pmid:13570054
Zagar Z [Antimicrobial therapy and public health]. 1967 Wien. Klin. Wochenschr. pmid:5185251
Breitfellner G and Neuhold R [Yearly variations of the lysotype and resistance picture of staphylococci]. 1968 Wien. Klin. Wochenschr. pmid:4232544
Rytel MW and Coonrod JD Therapy of viral, mycoplasmal and rickettsial infections. 1971 Wis. Med. J. pmid:4101370
Chusid MJ et al. Neutropenia in dysgammaglobulinemia I: remission with immunoglobulin therapy. 1981 Wis. Med. J. pmid:7281709
Larratt K et al. Sporadic cases of Legionnaires' disease in Wisconsin: epidemiologic and clinical characteristics. 1980 Wis. Med. J. pmid:7210696
Krone LV The importance of multiple antibiotic coverage for hospitalized patients when the community acquired pneumonia is Legionnaire's disease. 1998 WMJ pmid:9617308
Matsunaga H et al. Manometric evidence of improved early gastric stasis by erythromycin after pylorus-preserving pancreatoduodenectomy. 2000 World J Surg pmid:11071469
Raahave D et al. Cefotaxime i.v. versus oral neomycin-erythromycin for prophylaxis of infections after colorectal operations. 1988 World J Surg pmid:3041682
Condon RE Intestinal antisepsis: rationale and results. 1982 World J Surg pmid:7090403
Stone HH and Fabian TC Clinical comparison of antibiotic combinations in the treatment of peritonitis and related mixed aerobic-anaerobic surgical sepsis. 1980 World J Surg pmid:7233913
Attaran B et al. Effect of biofilm formation by clinical isolates of on the efflux-mediated resistance to commonly used antibiotics. 2017 World J. Gastroenterol. pmid:28275296
Niv E et al. Effect of erythromycin on image quality and transit time of capsule endoscopy: a two-center study. 2008 World J. Gastroenterol. pmid:18442206
Sári R et al. Ethanol inhibits the motility of rabbit sphincter of Oddi in vitro. 2004 World J. Gastroenterol. pmid:15526367
Liu ZQ et al. Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance. 2008 World J. Gastroenterol. pmid:18777600
Leung WK et al. Effect of oral erythromycin on gastric and small bowel transit time of capsule endoscopy. 2005 World J. Gastroenterol. pmid:16097060
Lim CH et al. Effect of DA-9701 on gastric emptying in a mouse model: assessment by ¹³C-octanoic acid breath test. 2013 World J. Gastroenterol. pmid:23885150
Jiang DP et al. Treatment of pediatric Ogilvie's syndrome with low-dose erythromycin: a case report. 2007 World J. Gastroenterol. pmid:17461506
Suchitra AD et al. Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in mice. 2003 World J. Gastroenterol. pmid:12679931
Ung D et al. Metabolic interactions between prokinetic agents domperidone and erythromycin: an in vitro analysis. 2009 Xenobiotica pmid:19575604
Hu J et al. Possible multiple transporters were involved in hepatobiliary excretion of antofloxacin in rats. 2007 Xenobiotica pmid:17614005
Salimi A et al. Toxicity of macrolide antibiotics on isolated heart mitochondria: a justification for their cardiotoxic adverse effect. 2016 Xenobiotica pmid:26068526
Emoto C et al. Cooperativity of alpha-naphthoflavone in cytochrome P450 3A-dependent drug oxidation activities in hepatic and intestinal microsomes from mouse and human. 2001 Xenobiotica pmid:11491388
Bickel MH et al. Entero-bacterial formation of cyclohexylamine in rats ingesting cyclamate. 1974 Xenobiotica pmid:4372812
Yamazaki H et al. Effects of roxithromycin, erythromycin and troleandomycin on their N-demethylation by rat and human cytochrome P450 enzymes. 1996 Xenobiotica pmid:8948090
Pasic J et al. The interaction between chronic oral slow-release theophylline and single-dose intravenous erythromycin. 1987 Xenobiotica pmid:3604256
Yamazaki H and Shimada T Formation in vitro of an inhibitory cytochrome P450 x Fe2+-metabolite complex with roxithromycin and its decladinosyl, O-dealkyl and N-demethyl metabolites in rat liver microsomes. 1998 Xenobiotica pmid:9849646
Saitoh R et al. Nonlinear intestinal pharmacokinetics of mitemcinal, the first acid-resistant non-peptide motilin receptor agonist, in rats. 2007 Xenobiotica pmid:17926229
Berg-Candolfi M et al. Suppression of intestinal and hepatic cytochrome P4503A in murine Toxoplasma infection. Effects of N-acetylcysteine and N(G)-monomethyl-L-arginine on the hepatic suppression. 1996 Xenobiotica pmid:9173679
Villa P et al. Erythromycin toxicity in primary cultures of rat hepatocytes. 1985 Aug-Sep Xenobiotica pmid:4072263
Ward KW et al. Exploration of the African green monkey as a preclinical pharmacokinetic model: oral pharmacokinetic parameters and drug-drug interactions. 2009 Xenobiotica pmid:19280525
Ward KW et al. Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human. 2005 Xenobiotica pmid:16019946
Molnari JC and Myers AL Carbonyl reduction of bupropion in human liver. 2012 Xenobiotica pmid:22339467
Kaye B and Roberts DW The metabolism of oxamniquine in the gut wall. 1980 Xenobiotica pmid:7395269
Watanabe M et al. Role of CYP3A in bromperidol metabolism in rat in vitro and in vivo. 1999 Xenobiotica pmid:10553724
Kubo JI et al. Pharmacokinetic evaluation of high pulmonary disposition of clarithromycin after systemic administration. 2002 Xenobiotica pmid:12419017
Trepanier LA and Miller JL NADH-dependent reduction of sulphamethoxazole hydroxylamine in dog and human liver microsomes. 2000 Xenobiotica pmid:11307968
Guillouzo A et al. Human hepatocyte cultures: a model of pharmaco-toxicological studies. 1985 Aug-Sep Xenobiotica pmid:3907158
Kanazu T et al. Model for the drug-drug interaction responsible for CYP3A enzyme inhibition. I: evaluation of cynomolgus monkeys as surrogates for humans. 2004 Xenobiotica pmid:15370956
Zhang Y et al. [Erythromycin restores oxidative stress-induced corticosteroid responsiveness of human THP-1 cells by up-regulating the expression of histone deacetylase 2]. 2014 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi pmid:24721407
Watanabe Y et al. [Relationship between quality and serum level after the oral administration of commercial erythromycin tablets in man (author's transl)]. 1977 Yakugaku Zasshi pmid:911413
Matsuoka M [Study of macrolide, lincosamide, and streptogramin B antibiotics resistance in Staphylococcus aureus]. 2000 Yakugaku Zasshi pmid:10774259
Nakamura H et al. Effect of particle size on mixing degree in dispensation. 2004 Yakugaku Zasshi pmid:15049131
Nakamura H et al. Effect of mixing method on the mixing degree during the preparation of triturations. 2004 Yakugaku Zasshi pmid:15049130
Watanabe Y et al. [Effect of dissolving pH of enteric coating agent on bioavailability of enteric coated tablets of erythromycin in man (author's transl)]. 1978 Yakugaku Zasshi pmid:30834
Miyazaki M et al. [Trends and antimicrobial susceptibilities of clinical methicillin-resistant Staphylococcus aureus isolates in Fukuoka University Chikushi Hospital 2008-2012]. 2014 Yakugaku Zasshi pmid:24492229
Otsuka M et al. [Studies on fungicides. XIV. Effect of erythromycin on the growth of fungal mycelia (author's transl)]. 1978 Yakugaku Zasshi pmid:566318
Xu P et al. [Synthesis of derivatives of (9S) -9-hydroxyl-12-methylene erythromycin A and their antibacterial activity in vitro]. 2007 Yao Xue Xue Bao pmid:17703771
Chen SX et al. [Synthesis and antibacterial activity of 3-hydroxy-6-O-methylerythromycin-9-O-substituted oxime derivatives]. 2001 Yao Xue Xue Bao pmid:12579933